InMed Pharmaceuticals Inc.
INM
$0.88
-$0.01-1.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.03M | -1.73M | -1.79M | -2.12M | -2.58M |
| Total Depreciation and Amortization | 158.00K | 156.70K | 131.10K | 129.60K | 129.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.40K | 21.60K | 59.60K | 66.40K | 37.40K |
| Change in Net Operating Assets | -602.40K | -59.00K | -180.90K | 265.40K | -93.50K |
| Cash from Operations | -2.38M | -1.61M | -1.78M | -1.66M | -2.50M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 8.79M | 2.94M | 396.20K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -137.20K | -619.40K | -15.10K | -57.60K |
| Cash from Financing | 0.00 | -137.20K | 8.17M | 2.92M | 338.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.38M | -1.74M | 6.40M | 1.26M | -2.16M |